Table 1.
Study name | Study design | Country, period | Setting | Study population (age range) | Subgroups | Type of HF | Sample size | Gender | Cases (n) | (%) | Per 100,000 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Female (n) | Female (%) | |||||||||||
Incidence of HF as a primary diagnosis | ||||||||||||
Andrews [13] | Prospective | UK and Ireland, 2003 (1 year) | Hospitals (17) | Hospitalized HF cases (0–16 years) | All patients | HF | 11,712,100* | NR | NR | 104 | NR | 0.87 |
Massin [17] | Prospective | Belgium, 1996–2006 (10 years) | Hospital (1) | Hospitalized cases (0–16 years) | All patients | HF | 1196 | 620 | 51.8* | 124 | 10.4 | – |
Neumann [14] | Retrospective | Germany, 2000–2006 (7 years) | Country wide hospitals | Hospitalized HF cases (0–< 15 years) | Years 2000–2006 (7 years) | HF | NR | NR | NR | NR | NR | 2.0–3.0 |
Schmidt [15] | Retrospective | Germany, 1995 and 2009 (2 distinct years) | Country wide hospitals | Hospitalized HF cases | Year 1995 | HF | 1,32,38,000 | NR | NR | 265 | NR | 2 |
Year 2009 | HF | 1,10,30,000 | NR | NR | 221 | NR | 2 | |||||
Tseng [16] | Retrospective | Taiwan, 2005 (1 year) | Country wide hospitals | Hospitalized HF cases (0–14 years) | All patients | HF | 190,362* | 90,873 | 47.7 | 14* | NR | 7.4* |
0–4 years | HF | 55,262 | 26,319 | 47.6 | 12 | NR | 21.7 | |||||
5–9 years | HF | 65,636 | 31,355 | 47.8 | 0 | NR | 0 | |||||
10–14 years | HF | 69,464 | 33,199 | 47.8 | 2 | NR | 2.9 | |||||
Males | 0–14 years | HF | 99,489* | – | – | 6 | NR | 6.0* | ||||
Females | 0–14 years | HF | 90,873* | 90,873 | 100 | 8* | NR | 8.8* | ||||
Prevalence of HF as a primary diagnosis | ||||||||||||
Adekanmbi [18] | Prospective | Nigeria, 2002–2003 (1 year) | Hospital (1) | Hospital admissions and ER | All patients | Congestive HF | 1552 | NR | NR | 109 | 7 | – |
(1 day–14 years) | ||||||||||||
Animasahun [19] | Prospective | Nigeria, 2011–2012 (2 years) | Hospital (1) | Hospital admissions | All patients | Congestive HF | 5705 | NR | NR | 156 | 2.7 | – |
(1 day–12 years) | ||||||||||||
Jiménez-García [20] | Cross-sectional | Spain, 2012–2013 (1 year) | Community (Madrid) | Influenza vaccination coverage (6 months–14 years) |
HF | 9,81,855 | 4,77,928 | 48.7 | 818 | 0.1 | 83.3* | |
Rodríguez-Rieiro [21] | Spain, 2009 (point prevalence) | Patients with chronic diseases | HF | 1,17,940 | 48,806 | 41.4 | 689 | 0.6* | 77$ | |||
Lagunju [22] | Prospective | Nigeria, 2000–2001 (10 months) | Hospital (1) | Hospital admissions (8 days–12 years) | All patients | Congestive HF | 1713 | NR | NR | 100 | 5.8 | – |
Oyedeji [23] | Prospective | Nigeria, 2007 (6 months) | Hospital (1) | Patients in ER (1 month–12 years) | All patients | Congestive HF | 391 | NR | NR | 35 | 9 | – |
ER emergency room, HF heart failure, NR not reported
*Calculated values from the source article
$Reported as prevalence of 7.7 per 10,000 inhabitants